unknown
Stage
About
Alentar is developing therapies aimed at reversing goblet cell hyperplasia to treat cystic fibrosis and other pulmonary conditions.
Explore Alentar's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.